186 results
Page 3 of 10
10-K
EX-10.66
trt1ljsvhaofveck84qa
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
nfma bwoxy8ik6
12 Feb 18
Annual report
12:00am
424B5
hi95w4c
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
3fwe3z3lygoezu7y rp
13 Jul 16
Current report (foreign)
12:00am
424B5
55ye83jhwy2n9sb 9sq
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
v4pid
30 Nov 15
Current report (foreign)
12:00am
424B5
46qp6vur24
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
ild6oeqb
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
lu7cz5413r
8 Jun 15
Business combination disclosure
12:00am
425
jk4ats32f5pfjgzx3dm
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
z67qmb
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
6-K
85n14ggyq6h4rq n1qt
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
vhxqm0epb hcwfc
3 Jun 14
Live Filing
12:00am
6-K
vgho5
31 Oct 13
Current report (foreign)
12:00am
6-K
EX-99.1
s4nxhejy mr872g7y
1 Aug 13
Teva Reports Second Quarter 2013 Results
12:00am
6-K
9aj5u
2 May 13
Current report (foreign)
12:00am